- Home
- FC vs SRZN Comparison
FC vs SRZN Comparison
Compare FC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FC | SRZN |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.2M | 304.3M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | FC | SRZN |
|---|---|---|
| Price | $23.93 | $21.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $26.00 | ★ $38.00 |
| AVG Volume (30 Days) | 56.4K | ★ 71.8K |
| Earning Date | 04-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $267,067,000.00 | N/A |
| Revenue This Year | $3.15 | $75.35 |
| Revenue Next Year | $4.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.16 | $8.00 |
| 52 Week High | $24.82 | $35.00 |
Technical Indicators
Market Signals| Indicator | FC | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 60.68 | 31.41 |
| Support Level | $20.36 | $20.02 |
| Resistance Level | $24.13 | $24.50 |
| Average True Range (ATR) | 1.07 | 1.99 |
| MACD | 0.03 | -0.46 |
| Stochastic Oscillator | 75.70 | 1.25 |
Price Performance
Historical ComparisonAbout FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).